Mesenchymal stem cells suppress NF-κB and ERK signalling while enhancing chemotaxis in CD4+ T cells
Inflammation is regulated by immune cells, with CD4<sup>+</sup> T cells playing a key role in its progression and resolution. Modulating their response is crucial for controlling inflammation, and mesenchymal stem cells (MSCs) have emerged as a promising therapeutic target due to their immunomodulatory properties. We previously showed that umbilical cord derived MSCs (UC-MSCs) induce a memory response in TCR-activated CD4<sup>+</sup> T cells, and here, we investigated the underlying mechanisms through gene expression analysis at different time points. Our results demonstrated that TCR activation is required for UC-MSCs to induce this memory response. Pathway analysis revealed that UC-MSCs induced the expression of genes that negatively regulate immune signalling pathways. This was further supported by phosphoflow cytometry, which showed suppression of the NF-κB and ERK pathways. Additionally, UC-MSCs enhanced the expression of genes related to CD4<sup>+</sup> T cell adhesion and migration at 12 and 24 h. Notably, TNIP1 emerged as a potential key regulator of UC-MSCs-mediated immune modulation. This study provides new insights into how UC-MSCs influence CD4<sup>+</sup> T cell responses and highlights molecular targets for further investigation into UC-MSCs-driven immune regulation.
Authors
- Daan R. M. G. Ophelders (ORCID: https://orcid.org/0000-0001-7410-5102)
- Marc J. Eleveld (ORCID: https://orcid.org/0000-0001-7454-018X)
- Janeri Fröberg (ORCID: https://orcid.org/0000-0002-1487-3633)
- Hans J. P. M. Koenen (ORCID: https://orcid.org/0000-0003-1210-7502)
- Xuehui He (ORCID: https://orcid.org/0000-0002-3801-4091)
- Katja Möller‐Hackbarth
- Martijn A. Huynen (ORCID: https://orcid.org/0000-0001-6189-5491)
- Marien Isaäk de Jonge (ORCID: https://orcid.org/0000-0003-2812-5895)
- Tim G. A. M. Wolfs (ORCID: https://orcid.org/0000-0003-4417-4144)
- Ruben L. Smeets
- Renate G. van der Molen (ORCID: https://orcid.org/0000-0003-3113-6587)
- Ezgi Sengun
Institutions
- Radboud University Nijmegen (NL)
- Maastricht University Medical Centre (NL)
- Radboud University Medical Center (NL)
- Maastricht University (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- Asarina Pharma (Sweden) (SE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1038/s41598-025-14373-6
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission